Katona, T., Tóth, G., Petró, M., Harangi, B.: Advanced Multi-Label Image Classification Techniques Using Ensemble Methods.
Mach. Learn. Knowl. Extr. 6 (2), 1281-1297, 2024.

Hevessy, Z., Tóth, G., Antal-Szalmás, P., Tőkés-Füzesi, M., Kappelmayer, J., Kárai, B., Ajzner, É., Working Group on Guidelines, Algorithms of the Hungarian Society of Laboratory Medicine: Algorithm of differential diagnosis of anemia involving laboratory medicine specialists to advance diagnostic excellence.
Clin. Chem. Lab. Med. 62 (3), 410-420, 2024.

Katona, T., Tóth, G., Petró, M., Harangi, B.: Developing New Fully Connected Layers for Convolutional Neural Networks with Hyperparameter Optimization for Improved Multi-Label Image Classification.
Mathematics. 12 (6), 1-16, 2024.

Sebestyén, E., Major, N., Bodoki, L., Makai, A., Balogh, I., Tóth, G., Orosz, Z., Árkosy, P., Vaskó, A., Hódosi, K., Szekanecz, Z., Szekanecz, É., Hungarian OncoRheumatology Network (HORN) initiative: Immune-related adverse events of anti-PD-1 immune checkpoint inhibitors: a single center experience.
Front Oncol. 13 1-9, 2023.

Fazekas, L., Szabó, B., Szegeczki, V., Fillér, C., Varga, Á., Godó, Z., Tóth, G., Reglődi, D., Juhász, T., Németh, N.: Impact Assessment of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and Hemostatic Sponge on Vascular Anastomosis Regeneration in Rats.
Int. J. Mol. Sci. 24 1-24, 2023.

Tóth, G., Szöllősi, J., Abken, H., Vereb, G., Szöőr, Á.: A Small Number of HER2 Redirected CAR T Cells Significantly Improves Immune Response of Adoptively Transferred Mouse Lymphocytes against Human Breast Cancer Xenografts.
Int. J. Mol. Sci. 21 (3), 1-11, 2020.

Szöőr, Á., Tóth, G., Zsebik, B., Szabó, V., Eshhar, Z., Abken, H., Vereb, G.: Trastuzumab Derived HER2-specific CARs for the Treatment of Trastuzumab-Resistant Breast Cancer: CAR T Cells Penetrate and Eradicate Tumors That Are Not Accessible to Antibodies.
Cancer Lett. 484 1-8, 2020.

Tóth, G., Szöllősi, J., Vereb, G.: Quantitating ADCC against adherent cells: impedance-based detection is superior to release, membrane permeability, or caspase activation assays in resolving antibody dose response.
Cytom. Part A. 91 (10), 1021-1029, 2017.

Szöőr, Á., Ujlaky-Nagy, L., Tóth, G., Szöllősi, J., Vereb, G.: Cell confluence induces switching from proliferation to migratory signaling by site-selective phosphorylation of PDGF receptors on lipid raft platforms.
Cell. Signal. 28 (2), 81-93, 2016.

Tóth, G., Szöőr, Á., Simon, L., Yarden, Y., Szöllősi, J., Vereb, G.: The combination of trastuzumab and pertuzumab administered at approved doses may delay development of trastuzumab resistance by additively enhancing antibody-dependent cell-mediated cytotoxicity.
mAbs. 8 (7), 1361-1370, 2016.

Roszik, J., Tóth, G., Szöllősi, J., Vereb, G.: Validating pharmacological disruption of protein-protein interactions by acceptor photobleaching FRET imaging.
In: Target Identification and Validation in Drug Discovery. Eds.: Jürgen Moll, Riccardo Colombo, Humana Press, Totowa, NJ, 165-78, 2013. ISBN: 9781627033107